"It’s wonderful to now see clear recognition of the value nationally coordinated biobanking delivers, both economically and for patients."
Robyn Leonard OAM, Founder and Director, Brain Cancer Australia
Robyn Leonard OAM, Founder and Director, Brain Cancer Australia
New report shows coordinated biobanking could deliver $39 million in value.
Australia’s national science agency, CSIRO, has highlighted the critical role of biobanking in driving faster medical breakthroughs.
Biobanks are collections of donated tissue and data that researchers can access to better understand diseases like brain cancer, test new ideas, and develop more effective treatments. They’re one of the most powerful tools we have to accelerate medical research – but often don’t have the profile or investment they deserve.
CSIRO’s new report shows that better coordination of biobanks across the country could deliver $39 million of value every year – by avoiding duplication, improving access to samples, and speeding up research.
At Brain Cancer Australia, we’ve already taken big steps by networking 20 biobanks and more than 11,000 brain cancer tissue samples into a national platform with global access. We are now moving to the next phase – establishing national standards to harmonise brain cancer biobanking and the development of advanced brain tumour models to help researchers find better treatments, sooner.
"I’ve been banging on about the importance of nationally networked biobanking for over a decade - so it’s wonderful to now see clear recognition of the value this delivers, both economically and for patients," said Robyn Leonard OAM, Founder and Director, Brain Cancer Australia.
Find out more about the research infrastructure that will give everyone who can help defeat brain cancer what they need to do it.
Read the CSIRO Futures Report on the Valuation of Increased Coordination in Australian Biobanking.
Biobanks are collections of donated tissue and data that researchers can access to better understand diseases like brain cancer, test new ideas, and develop more effective treatments. They’re one of the most powerful tools we have to accelerate medical research – but often don’t have the profile or investment they deserve.
CSIRO’s new report shows that better coordination of biobanks across the country could deliver $39 million of value every year – by avoiding duplication, improving access to samples, and speeding up research.
At Brain Cancer Australia, we’ve already taken big steps by networking 20 biobanks and more than 11,000 brain cancer tissue samples into a national platform with global access. We are now moving to the next phase – establishing national standards to harmonise brain cancer biobanking and the development of advanced brain tumour models to help researchers find better treatments, sooner.
"I’ve been banging on about the importance of nationally networked biobanking for over a decade - so it’s wonderful to now see clear recognition of the value this delivers, both economically and for patients," said Robyn Leonard OAM, Founder and Director, Brain Cancer Australia.
Find out more about the research infrastructure that will give everyone who can help defeat brain cancer what they need to do it.
Read the CSIRO Futures Report on the Valuation of Increased Coordination in Australian Biobanking.
